Team-Based Care with Pharmacists to Improve Blood Pressure: a Review of Recent Literature

Current Hypertension Reports

Volumn 20, Issue 1, 2018, Pages

  Kennelty, Korey A ^a,b   Polgreen, Linnea A ^a   Carter, Barry L ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Blood pressure; Cost effectiveness; Dissemination and implementation; Hypertension; Intervention sustainability; Team care

Indexed keywords

ACCESS TO INFORMATION; BLOOD PRESSURE REGULATION; COST EFFECTIVENESS ANALYSIS; HEALTH CARE MANAGEMENT; HEALTH CARE PLANNING; HUMAN; INFORMATION DISSEMINATION; PATIENT CARE; PHARMACIST; PRIMARY MEDICAL CARE; PROGRAM SUSTAINABILITY; REIMBURSEMENT; REVIEW; STAKEHOLDER ENGAGEMENT; TEAM BASED CARE; HYPERTENSION; PHYSICIAN ATTITUDE;

HUMANS; HYPERTENSION; PATIENT CARE MANAGEMENT; PATIENT CARE TEAM; PHARMACISTS; PHYSICIAN'S ROLE;

EID: 85040768947     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-018-0803-0     Document Type: Review

References (73)

1. Merai R, Siegel C, Rakotz M, Basch P, Wright J, Wong B, et al. CDC grand rounds: a public health approach to detect and control hypertension. MMWR Morb Mortal Wkly Rep. 2016;65(45):1261–4. https://doi.org/10.15585/mmwr.mm6545a3.
2. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics—2012 update: a report from the American Heart Association. Circulation. 2012;125(1):e2–e220. https://doi.org/10.1161/CIR.0b013e31823ac046.
3. Yoon SS, Fryar CD, Carroll MD, National Center for Health Statistics, National Health, Nutrition Examination Survey. Hypertension prevalence and control among adults: United States, 2011–2014. 2015.
4. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ (Clinical research ed). 2009;338:b1665. https://doi.org/10.1136/bmj.b1665.
5. Staessen JA, Wang JG, Thijs L. What can be expected from optimal blood pressure control? J Hypertens Suppl. 2003;21(2):S3–9. https://doi.org/10.1097/00004872-200305002-00002.
6. Carter BL, Ardery G, Dawson JD, James PA, Bergus GR, Doucette WR, et al. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med. 2009;169(21):1996–2002. https://doi.org/10.1001/archinternmed.2009.358.
7. Carter BL, Bergus GR, Dawson JD, Farris KB, Doucette WR, Chrischilles EA, et al. A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control. J Clin Hypertens (Greenwich). 2008;10(4):260–71. https://doi.org/10.1111/j.1751-7176.2008.07434.x.
8. Carter BL, Bosworth HB, Green BB. The hypertension team: the role of the pharmacist, nurse, and teamwork in hypertension therapy. J Clin Hypertens (Greenwich). 2012;14(1):51–65. https://doi.org/10.1111/j.1751-7176.2011.00542.x.
9. Rudd P, Miller NH, Kaufman J, Kraemer HC, Bandura A, Greenwald G, et al. Nurse management for hypertension. A systems approach. Am J Hypertens. 2004;17(10):921–7. https://doi.org/10.1016/j.amjhyper.2004.06.006.
10. Logan AG, Milne BJ, Achber C, Campbell WP, Haynes RB. Work-site treatment of hypertension by specially trained nurses. A controlled trial. Lancet (London, England). 1979;2(8153):1175–8.
11. Carter BL, Rogers M, Daly J, Zheng S, James PA. The potency of team-based care interventions for hypertension. Arch Intern Med. 2009;169(19):1748–55. https://doi.org/10.1001/archinternmed.2009.316.
12. Naylor MD, Coburn KD, Kurtzman ET, Prvu Bettger JA, Buck H, Van Cleave J et al. Inter-professional team-based primary care for chronically ill adults: state of the science. 2010.
13. Mitchell P, Wynia M, Golden R, McNellis B, Okun S, Webb CE et al. Core principles & values of effective team-based health care. 2012.
14. Coleman K, Reid R. Continuous and team-based healing relationships: improving patient care through teams. Safety Net Medical Home Initiative Implementation Guide Series 2013.
15. Wagner EH. The role of patient care teams in chronic disease management. BMJ. 2000;320(7234):569–72. https://doi.org/10.1136/bmj.320.7234.569.
16. Wagner EH, Reid RJ. Are continuity of care and teamwork incompatible? Med Care. 2007;45(1):6–7. https://doi.org/10.1097/01.mlr.0000253165.03466.e3.
17. Davis BR, Kostis JB, Simpson LM, Black HR, Cushman WC, Einhorn PT, et al. Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Circulation. 2008;118(22):2259–67. https://doi.org/10.1161/CIRCULATIONAHA.107.762229.
18. Audet AM, Davis K, Schoenbaum SC. Adoption of patient-centered care practices by physicians: results from a national survey. Arch Intern Med. 2006;166(7):754–9. https://doi.org/10.1001/archinte.166.7.754.
19. Feifer C, Nemeth L, Nietert PJ, Wessell AM, Jenkins RG, Roylance L, et al. Different paths to high-quality care: three archetypes of top-performing practice sites. Ann Fam Med. 2007;5(3):233–41. https://doi.org/10.1370/afm.697.
20. O’Malley AS, Forrest CB, Politzer RM, Wulu JT, Shi L. Health center trends, 1994–2001: what do they portend for the federal growth initiative? Health Aff (Millwood). 2005;24(2):465–72. https://doi.org/10.1377/hlthaff.24.2.465.
21. Phelan EA, Balderson B, Levine M, Erro JH, Jordan L, Grothaus L, et al. Delivering effective primary care to older adults: a randomized, controlled trial of the senior resource team at group health cooperative. J Am Geriatr Soc. 2007;55(11):1748–56. https://doi.org/10.1111/j.1532-5415.2007.01416.x.
22. Rosenthal T, Campbell-Heider N. The rural health care team. In: Geyman JPNT, Hart G, editors. Textbook of rural health care. New York: Mcgraw-Hill; 2001.
23. Grumbach K, Bodenheimer T. Can health care teams improve primary care practice? JAMA. 2004;291(10):1246–51. https://doi.org/10.1001/jama.291.10.1246.
24. Howard J, Etz RS, Crocker JB, Skinner D, Kelleher KJ, Hahn KA, et al. Maximizing the Patient-Centered Medical Home (PCMH) by choosing words wisely. J Am Board Fam Med. 2016;29(2):248–53. https://doi.org/10.3122/jabfm.2016.02.150199.
25. Balasubramanian BA, Fernald D, Dickinson LM, Davis M, Gunn R, Crabtree BF, et al. REACH of interventions integrating primary care and behavioral health. J Am Board Fam Med. 2015;28(Suppl 1):S73–85. https://doi.org/10.3122/jabfm.2015.S1.150055.
26. Cohen DJ, Balasubramanian BA, Davis M, Hall J, Gunn R, Stange KC, et al. Understanding care integration from the ground up: five organizing constructs that shape integrated practices. J Am Board Fam Med. 2015;28(Suppl 1):S7–20. https://doi.org/10.3122/jabfm.2015.S1.150050.
27. Solberg LI, Crain AL, Tillema JO, Fontaine PL, Whitebird RR, Flottemesch TJ, et al. Challenges of medical home transformation reported by 118 patient-centered medical home (PCMH) leaders. J Am Board Fam Med. 2014;27(4):449–57. https://doi.org/10.3122/jabfm.2014.04.130303.
28. Crabtree BF, Chase SM, Wise CG, Schiff GD, Schmidt LA, Goyzueta JR, et al. Evaluation of patient centered medical home practice transformation initiatives. Med Care. 2011;49(1):10–6. https://doi.org/10.1097/MLR.0b013e3181f80766.
29. Carter BL. Blood pressure control—implementing a team approach. US Cardiol. 2011;8(2):108–13.
30. • Carter BL, Coffey CS, Ardery G, Uribe L, Ecklund D, James P, et al. Cluster-randomized trial of a physician/pharmacist collaborative model to improve blood pressure control. Circ Cardiovasc Qual Outcomes. 2015;8(3):235–43. https://doi.org/10.1161/CIRCOUTCOMES.114.001283. Findings suggest that team-based care utilizing clinical pharmacists in diverse primary care offices reduced mean BP in subjects from racial minority groups.
31. Anderegg MD, Gums TH, Uribe L, Coffey CS, James PA, Carter BL. Physician-pharmacist collaborative management: narrowing the socioeconomic blood pressure gap. Hypertension. 2016;68(5):1314–20. https://doi.org/10.1161/hypertensionaha.116.08043.
32. Gums T, Uribe L, Vander Weg MW, James P, Coffey C, Carter BL. Pharmacist intervention for blood pressure control: medication intensification and adherence. J Am Soc Hypertens. 2015;9(7):569–78. https://doi.org/10.1016/j.jash.2015.05.005.
33. DeMik DE, Vander Weg MW, Lundt ES, Coffey CS, Ardery G, Carter BL. Using theory to predict implementation of a physician–pharmacist collaborative intervention within a practice-based research network. Res Soc Admin Pharm. 2013;9(6):719–30. https://doi.org/10.1016/j.sapharm.2013.01.003.
34. Carter BL. Primary care physician-pharmacist collaborative care model: strategies for implementation. Pharmacotherapy. 2016;36(4):363–73. https://doi.org/10.1002/phar.1732.
35. • Tsuyuki RT, Houle SK, Charrois TL, Kolber MR, Rosenthal MM, Lewanczuk R, et al. Randomized trial of the effect of pharmacist prescribing on improving blood pressure in the community: the Alberta Clinical Trial in Optimizing Hypertension (RxACTION). Circulation. 2015;132(2):93–100. https://doi.org/10.1161/circulationaha.115.015464. Pharmacists had independent prescriptive authority after meeting several requirements. Pharmacists prescribing for patients with hypertension resulted in significant BP reduction.
36. Tsuyuki RT, Al Hamarneh YN, Jones CA, Hemmelgarn BR. The effectiveness of pharmacist interventions on cardiovascular risk: the multicenter randomized controlled RxEACH trial. J Am Coll Cardiol. 2016;67(24):2846–54. https://doi.org/10.1016/j.jacc.2016.03.528.
37. Panattoni L, Hurlimann L, Wilson C, Durbin M, Tai-Seale M. Workflow standardization of a novel team care model to improve chronic care: a quasi-experimental study. BMC Health Serv Res. 2017;17(1):286. https://doi.org/10.1186/s12913-017-2240-1.
38. Polgreen LA, Han J, Carter BL, Ardery GP, Coffey CS, Chrischilles EA, et al. Cost-effectiveness of a physician-pharmacist collaboration intervention to improve blood pressure control. Hypertension. 2015;66(6):1145–51. https://doi.org/10.1161/HYPERTENSIONAHA.115.06023.
39. • Simpson SH, Lier DA, Majumdar SR, Tsuyuki RT, Lewanczuk RZ, Spooner R, et al. Cost-effectiveness analysis of adding pharmacists to primary care teams to reduce cardiovascular risk in patients with type 2 diabetes: results from a randomized controlled trial. Diabet Med. 2015;32(7):899–906. https://doi.org/10.1111/dme.12692. They found that a pharmacist-physician intervention among patients with type 2 diabetes was cost effective for 95% of the scenarios they tested if society is willing to spend $4000 CAD per 1% reduction in cardiovascular risk.
40. Ladhani NN, Majumdar SR, Johnson JA, Tsuyuki RT, Lewanczuk RZ, Spooner R, et al. Adding pharmacists to primary care teams reduces predicted long-term risk of cardiovascular events in type 2 diabetic patients without established cardiovascular disease: results from a randomized trial. Diabet Med. 2012;29(11):1433–9. https://doi.org/10.1111/j.1464-5491.2012.03673.x.
41. • Kulchaitanaroaj P, Brooks JM, Chaiyakunapruk N, Goedken AM, Chrischilles EA, Carter BL. Cost-utility analysis of physician-pharmacist collaborative intervention for treating hypertension compared with usual care. J Hypertens. 2017;35(1):178–87. https://doi.org/10.1097/hjh.0000000000001126. The authors found that the pharmacist-physician intervention for hypertension was most cost-effective in the long term for the highest risk patients.
42. Marra C, Johnston K, Santschi V, Tsuyuki RT. Cost-effectiveness of pharmacist care for managing hypertension in Canada. Can Pharm J. 2017;150(3):184–97. https://doi.org/10.1177/1715163517701109.
43. Sullivan PW, Ghushchyan V. Preference-Based EQ-5D index scores for chronic conditions in the United States. Med Decis Making. 2006;26(4):410–20. https://doi.org/10.1177/0272989x06290495.
44. Kulchaitanaroaj P, Brooks JM, Ardery G, Newman D, Carter BL. Incremental costs associated with physician and pharmacist collaboration to improve blood pressure control. Pharmacotherapy. 2012;32(8):772–80. https://doi.org/10.1002/j.1875-9114.2012.01103.x.
45. • Kislan MM, Bernstein AT, Fearrington LR, Ives TJ. Advanced practice pharmacists: a retrospective evaluation of the efficacy and cost of ClinicaL Pharmacist PractitionErs managing ambulatory Medicare patients in North Carolina (APPLE-NC). BMC Health Serv Res. 2016;16(1):607. https://doi.org/10.1186/s12913-016-1851-2. The authors found that an established pharmacist-physician collaboration was cost neutral: adding pharmacists to the care team did not increase costs.
46. Carter BL, Ardery G. Avoiding pitfalls with implementation of randomized controlled multicenter trials: strategies to achieve milestones. J Am Heart Assoc. 2016;5(12):e004432. https://doi.org/10.1161/jaha.116.004432.
47. Carter BL, Levy BT, Gryzlak B, Chrischilles EA, Vander Weg MW, Christensen AJ, et al. A centralized cardiovascular risk service to improve guideline adherence in private primary care offices. Contemp Clin Trials. 2015;43:25–32. https://doi.org/10.1016/j.cct.2015.04.014.
48. Carter BL, Coffey CS, Chrischilles EA, Ardery G, Ecklund D, Gryzlak B, et al. A cluster-randomized trial of a centralized clinical pharmacy cardiovascular risk service to improve guideline adherence. Pharmacotherapy. 2015;35(7):653–62. https://doi.org/10.1002/phar.1603.
49. Carter BL, Clarke W, Ardery G, Weber CA, James PA, Vander Weg M, et al. A cluster-randomized effectiveness trial of a physician-pharmacist collaborative model to improve blood pressure control. Circ Cardiovasc Qual Outcomes. 2010;3(4):418–23. https://doi.org/10.1161/CIRCOUTCOMES.109.908038.
50. Glasgow RE, Vinson C, Chambers D, Khoury MJ, Kaplan RM, Hunter C. National Institutes of Health approaches to dissemination and implementation science: current and future directions. Am J Public Health. 2012;102(7):1274–81. https://doi.org/10.2105/ajph.2012.300755.
51. Proctor E, Luke D, Calhoun A, McMillen C, Brownson R, McCrary S, et al. Sustainability of evidence-based healthcare: research agenda, methodological advances, and infrastructure support. Implement Sci. 2015;10(1):88. https://doi.org/10.1186/s13012-015-0274-5.
52. Massatti RR, Sweeney HA, Panzano PC, Roth D. The de-adoption of innovative mental health practices (IMHP): why organizations choose not to sustain an IMHP. Admin Pol Ment Health. 2008;35(1–2):50–65. https://doi.org/10.1007/s10488-007-0141-z.
53. Scheirer MA. The life cycle of an innovation: adoption versus discontinuation of the fluoride mouth rinse program in schools. J Health Soc Behav. 1990;31(2):203–15. https://doi.org/10.2307/2137173.
54. Seffrin B, Panzano PC, Roth D. What gets noticed: how barrier and facilitator perceptions relate to the adoption and implementation of innovative mental health practices. Community Ment Health J. 2009;45(4):260–9. https://doi.org/10.1007/s10597-009-9222-7.
55. Ford JH, Krahn D, Wise M, Oliver KA. Measuring sustainability within the veterans administration mental health system redesign initiative. Qual Manag Health Care. 2011;20(4):263–79. https://doi.org/10.1097/QMH.0b013e3182314b20.
56. Wiltsey Stirman S, Kimberly J, Cook N, Calloway A, Castro F, Charns M. The sustainability of new programs and innovations: a review of the empirical literature and recommendations for future research. Implement Sci. 2012;7(1):17. https://doi.org/10.1186/1748-5908-7-17.
57. Rabin B, Brownson R. Developing the terminology for dissemination and implementation research. In: Brownson R, Colditz G, Proctor E, editors. Dissemination and implementation research in health: translating science to practice. New York: Oxford University Press; 2012. https://doi.org/10.1093/acprof:oso/9780199751877.003.0002.
58. Brownson RC, Jacobs JA, Tabak RG, Hoehner CM, Stamatakis KA. Designing for dissemination among public health researchers: findings from a national survey in the United States. Am J Public Health. 2013;103(9):1693–9. https://doi.org/10.2105/AJPH.2012.301165.
59. Isetts BJ, Buffington DE, Carter BL, Smith M, Polgreen LA, James PA. Evaluation of pharmacists’ work in a physician-pharmacist collaborative model for the management of Hypertension. Pharmacotherapy. 2016;36(4):374–84. https://doi.org/10.1002/phar.1727.
60. Bodenheimer T, Chen E, Bennett HD. Confronting the growing burden of chronic disease: can the U.S. health care workforce do the job? Health Aff (Millwood). 2009;28(1):64–74. https://doi.org/10.1377/hlthaff.28.1.64.
61. Smith M, Bates DW, Bodenheimer T, Cleary PD. Why pharmacists belong in the medical home. Health Aff (Millwood). 2010;29(5):906–13. https://doi.org/10.1377/hlthaff.2010.0209.
62. Bartholomew LK, Parcel GS, Kok G. Intervention mapping: a process for developing theory- and evidence-based health education programs. Health Educ Behav. 1998;25(5):545–63. https://doi.org/10.1177/109019819802500502.
63. Rogers EM. Diffusion of innovations. New York: The Free Press, A Division of Simon & Schuster, Inc.; 1995.
64. Weiner BJ. A theory of organizational readiness for change. Implement Sci. 2009;4(1):67. https://doi.org/10.1186/1748-5908-4-67.
65. Kerstenetzky L, Birschbach MJ, Beach KF, Hager DR, Kennelty KA. Improving medication information transfer between hospitals, skilled-nursing facilities, and long-term-care pharmacies for hospital discharge transitions of care: a targeted needs assessment using the Intervention Mapping framework. Res Soc Admin Pharm. 2017; https://doi.org/10.1016/j.sapharm.2016.12.013.
66. Green L, Kreuter M. Health program planning: an educational and ecological approach. New York: McGraw-Hill High Educ; 2005.
67. Harden SM, Gaglio B, Shoup JA, Kinney KA, Johnson SB, Brito F, et al. Fidelity to and comparative results across behavioral interventions evaluated through the RE-AIM framework: a systematic review. Syst Rev. 2015;4(1):155. https://doi.org/10.1186/s13643-015-0141-0.
68. Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999;89(9):1322–7. https://doi.org/10.2105/AJPH.89.9.1322.
69. Glasgow RE, McKay HG, Piette JD, Reynolds KD. The RE-AIM framework for evaluating interventions: what can it tell us about approaches to chronic illness management? Patient Educ Couns. 2001;44(2):119–27. https://doi.org/10.1016/S0738-3991(00)00186-5.
70. Forman J, Heisler M, Damschroder LJ, Kaselitz E, Kerr EA. Development and application of the RE-AIM QuEST mixed methods framework for program evaluation. Prev Med Rep. 2017;6(Supplement C):322–8. https://doi.org/10.1016/j.pmedr.2017.04.002.
71. Maher L, Gustafson D, Evans A. Sustainability model and guide. In: NHS Institute for Innovation and Improvement. 2010. http://webarchive.nationalarchives.gov.uk/20160805122935/http://www.nhsiq.nhs.uk/media/2757778/nhs_sustainability_model_-_february_2010_1_.pdf. Accessed 1 July 2017.
72. Kastner M, Sayal R, Oliver D, Straus SE, Dolovich L. Sustainability and scalability of a volunteer-based primary care intervention (Health TAPESTRY): a mixed-methods analysis. BMC Health Serv Res. 2017;17(1):514. https://doi.org/10.1186/s12913-017-2468-9.
73. Schell SF, Luke DA, Schooley MW, Elliott MB, Herbers SH, Mueller NB, et al. Public health program capacity for sustainability: a new framework. Implement Sci. 2013;8(1):15. https://doi.org/10.1186/1748-5908-8-15.